- Home
- >Origami Therapeutics, Inc.
Origami Therapeutics, Inc.
Oral drugs to halt neurodegeneration
Company
Locations
San Diego, CA, USA
Team Size
4
Industries
Healthcare, Therapeutics
About
Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our first indication is Huntington’s disease, a debilitating, progressive and ultimately fatal disorder caused by a genetic mutation. We have already identified small molecules that reduce the toxic mutated protein, suppress mutant protein-induced toxicities in human disease neurons and get into the brain. We anticipate that this approach will be broadly applicable to traditionally “undruggable” targets in other neurological diseases.
Founders
A list of all active founders
Sign-In
An account is required to download data from YCRM.
Almost There!
YCRM requires a one-time $30 payment to get access.
What You Get
- Unlimited downloads for 30 days
- 5000+ YC founders' email, LinkedIn, and Twitter
- Access to the latest YC batches
- Access to all CRM data enhancements
Payment Successful
Congrats! You now have unlimited access to the YCRM database for 30 days. If you have any questions or run into issues, please don't hesitate to reach out. We are here to help.
Name | Title | |||
---|---|---|---|---|
Beth Hoffman | Founder | Sign-InAn account is required to download data from YCRM. Almost There!YCRM requires a one-time $30 payment to get access. What You Get
Payment SuccessfulCongrats! You now have unlimited access to the YCRM database for 30 days. If you have any questions or run into issues, please don't hesitate to reach out. We are here to help. |